Chevron Corp
boothcheck covers Chevron Corp (CVX) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed July 25, 2026.
• Worldwide production averaged 3.86 million barrels of oil equivalent a day in the March quarter, up 15%, with the U.S. figure up 388,000 barrels a day or 24% on the strength of an acquisition. • Volume growth did not reach the bottom line: quarterly profit came to $2.2 billion, or $1.11 a share, against $3.5 billion and $2.00 a year earlier, with international refining earnings alone down $1.2 billion on ⟦"lower margins on refined product sales"⟧. • The declared quarterly dividend of $1.78 a
Is CVX overvalued? See what's priced in →
4,180 institutional managers reported holding CVX in 13F filings for the quarter ended 2026-03-31. Together they hold about 72% of the company; the top 10 hold 38%. 393 opened new positions that quarter. Held by Vanguard Group, State Street, BlackRock, among others. On the short side, 21.6M shares were sold short as of the 2026-06-15 count, about 1% of shares outstanding (2.7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CVX's share count grew 3.3% over the past five years even with $57.89B spent on repurchases. It pays a dividend, and has paid one every year in our records (18 and counting), raised 9 years straight; the current rate is $6.84 a share annually. Cash returned over the past three years: $33.74B in dividends and $37.13B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at CVX over the trailing three years. Absence is a fact about the company, not a signal. 26 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CVX's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-04 | -0.5% | +1.8% |
| 2023-11-03 | -6.7% | +1.9% |
| 2024-02-27 | +2.9% | +6.0% |
| 2024-05-03 | +0.4% | -3.7% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CVX's latest 8-K filings: 2026-07-31 (items 2.02, 9.01); 2026-05-29 (items 5.07); 2026-05-29 (items 5.02); 2026-05-01 (items 2.02, 9.01); 2026-04-09 (items 2.02).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.